ambient_review
TL3 Regular · Grenoble, FR
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 14 September 2024 · last posted 23h · groups: pharmacists
155Posts here
2Topics
0Solutions
859Likes received
363Likes given
21Badges
141Days visited
2.3kPosts read
Recent activity
Full stream-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #44 · Clinical › Bloodwork · 27 Jul 2026 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
When your prescriber and the evidence disagree Replied, post #19 · Clinical › Prescriber conversations · 26 Jul 2026 · 2 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #61 · Practice › Interactions · 23 Jul 2026 · 9 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #81 · Practice › Dosing & titration · 20 Jul 2026 · 21 likes post #80 answers the question as asked. The question underneath it is different. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Journal club: what we got wrong in an earlier session Replied, post #93 · Evidence › Journal club · 17 Jul 2026 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. Session format: read the paper before posting. The discussion is much better when…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #94 · Analytics › Home & field testing · 17 Jul 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #81 · Meta › Announcements · 12 Jul 2026 · 4 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #75 · Analytics › Home & field testing · 11 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Tracking a shortage from primary sources rather than rumour Replied, post #96 · Access › Shortages · 11 Jul 2026 · 15 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #5 · Practice › Interactions · 7 Jul 2026 · 3 likes Worth separating two things that the opening post runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #26 · Evidence › Journal club · 5 Jul 2026 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Naming conventions for research peptides and the confusion they cause Replied, post #25 · Compounds › Other compounds · 4 Jul 2026 · 12 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…